MYC Therapeutics is a private biotechnology company focusing on targeted protein degradation agents for MYC-driven malignancies.

MYC is a grand orchestrator of cancer growth and immune evasion which is altered / deregulated in ~70% of all human malignancies, driving tumor initiation, maintenance, and progression. It acts as a transcription factor, binding to DNA (partnered with MAX), amplifying gene expression, particularly those regulating cell growth, proliferation, and metabolism

Targeted protein degradation (TPD) hijacks the cell's natural disposal systems to selectively eliminate disease-causing proteins. Instead of merely blocking a protein’s function like traditional drugs, TPD agents catalytically tag and destroy the target protein completely.


MYC Therapeutics

Org chart

Teams

Offices

MYC Therapeutics

Org chart

Teams

Offices

Related companies